GlassScriptPhysician profile
Charles E Hyre
NPI 1811964406
$26,957.40
in general payments reported to CMS, 2019-2025
25 companies · $2,316 in 2025
The $2,316 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,456 · 2020: $2,724 · 2021: $3,373 · 2022: $11K · 2023: $936 · 2024: $2,559 · 2025: $2,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,014 · Travel and Lodging: $2,551 · Long Term Medical Supply Or Device Loan: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,013.74 |
| Travel and Lodging | $2,550.89 |
| Long Term Medical Supply Or Device Loan | $245.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,199.02 | 2022-2024 | Da Vinci Sp |
| Osiris Therapeutics INC. | $3,682.89 | 2019 | |
| Smith+Nephew, INC. | $3,460.57 | 2019-2025 | Oasis, Pico, Allevyn Gentle Border 10 X 10cm Ctn 10 |
| Takeda Pharmaceuticals U.S.A., INC. | $3,175.84 | 2020-2024 | Gattex |
| Davol INC. | $3,033.08 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,375.93 | 2020 | |
| Kerecis Limited | $584.81 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Stryker Corporation | $501.41 | 2022 | |
| Integra Lifesciences Corporation | $417.40 | 2020-2025 | Micromatrix, Integra, Integra Dermal Regeneration Template |
| Hydrofera LLC | $78.93 | 2024 | Hydrofera Blue |
| Conmed Corporation | $66.67 | 2022 | |
| Organogenesis INC. | $52.49 | 2022-2023 | Puraply |
| Innovation Technologies INC | $44.68 | 2022 | |
| Tela Bio, INC. | $41.10 | 2024 | Ovitex 2s |
| Solventum Corporation | $35.06 | 2024 | Prevena, V.A.C. Dermatac |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $30.46 | 2019 | |
| Lemaitre Vascular, INC. | $28.95 | 2024 | Artegraft Vascular Graft |
| Laminate Medical Technologies INC. | $26.00 | 2025 | Vasq |
| Avita Medical Americas, LLC | $25.89 | 2024 | |
| Abbvie INC. | $19.16 | 2022 | |
| Bioventus LLC | $19.04 | 2022 | |
| W. L. Gore & Associates, INC. | $15.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.72 | 2022 | |
| Teleflex LLC | $14.16 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Hyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.